Click for best price
AntiObesity Drugs Antiobesity Medication Market Size, Share 2022
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. These medications alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories.
This report contains market size and forecasts of Anti-Obesity Drugs (Anti-obesity Medication) in global, including the following market information:
Global top five Anti-Obesity Drugs (Anti-obesity Medication) companies in 2021 (%)
The global Anti-Obesity Drugs (Anti-obesity Medication) market was valued at 1876.9 million in 2021 and is projected to reach US$ 5385.2 million by 2028, at a CAGR of 16.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
by Drug Varieties Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Obesity Drugs (Anti-obesity Medication) include Zafgan, Vivus, Shionogi, Sanofi, Rhythm Pharmaceuticals, Pfizer, Orexigen Therapeutics, Novo Nordisk and Norgine, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Obesity Drugs (Anti-obesity Medication) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Obesity Drugs (Anti-obesity Medication) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segment Percentages, by Type, 2021 (%)
- by Drug Varieties
- Prescription Drugs
- OTC Drugs
- by Acting
- Peripherally Acting Anti-obesity Drugs
- Centrally Acting Anti-obesity Drugs
Global Anti-Obesity Drugs (Anti-obesity Medication) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segment Percentages, by Application, 2021 (%)
- Childhood (0-6)
- Juvenile (7-17)
- Youth (18-40)
- Middle Aged (41-60)
- Elderly (Above 60)
Global Anti-Obesity Drugs (Anti-obesity Medication) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Anti-Obesity Drugs (Anti-obesity Medication) revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Anti-Obesity Drugs (Anti-obesity Medication) revenues share in global market, 2021 (%)
- Key companies Anti-Obesity Drugs (Anti-obesity Medication) sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Anti-Obesity Drugs (Anti-obesity Medication) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Zafgan
- Vivus
- Shionogi
- Sanofi
- Rhythm Pharmaceuticals
- Pfizer
- Orexigen Therapeutics
- Novo Nordisk
- Norgine
- Nalpropion Pharmaceuticals Inc.
- Merck
- GlaxoSmithKline
- F.Hoffmann-La Roche
- Eisai
- Boehringer Ingelheim
- Bayer AG
- AstraZeneca
- Arena Pharmaceuticals
- Amylin
- Alizyme
| Report Attributes |
Report Details |
| Report Title |
Anti-Obesity Drugs (Anti-obesity Medication) Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
125 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Obesity Drugs (Anti-obesity Medication) Overall Market Size
2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size: 2021 VS 2028
2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales: 2017-2028
3 Company Landscape
3.1 Top Anti-Obesity Drugs (Anti-obesity Medication) Players in Global Market
3.2 Top Global Anti-Obesity Drugs (Anti-obesity Medication) Companies Ranked by Revenue
3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Companies
3.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Companies
3.5 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-Obesity Drugs (Anti-obesity Medication) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Obesity Drugs (Anti-obesity Medication) Players in Global Market
3.8.1 List of Global Tier 1 Anti-Obesity Drugs (Anti-obesity Medication) Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Obesity Drugs (Anti-obesity Medication) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Markets, 2021 & 2028
4.1.2 Prescription Drugs
4.1.3 OTC Drugs
4.2 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue & Forecasts
4.2.1 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2022
4.2.2 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2023-2028
4.2.3 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
4.3 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales & Forecasts
4.3.1 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2022
4.3.2 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2023-2028
4.3.3 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
4.4 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2021 & 2028
5.1.2 Childhood (0-6)
5.1.3 Juvenile (7-17)
5.1.4 Youth (18-40)
5.1.5 Middle Aged (41-60)
5.1.6 Elderly (Above 60)
5.2 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue & Forecasts
5.2.1 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2022
5.2.2 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2023-2028
5.2.3 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
5.3 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales & Forecasts
5.3.1 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2022
5.3.2 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2023-2028
5.3.3 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
5.4 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2021 & 2028
6.2 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue & Forecasts
6.2.1 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2022
6.2.2 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2023-2028
6.2.3 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
6.3 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales & Forecasts
6.3.1 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2022
6.3.2 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2023-2028
6.3.3 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2028
6.4.2 By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2028
6.4.3 US Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.4.4 Canada Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.4.5 Mexico Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2028
6.5.2 By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2028
6.5.3 Germany Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.4 France Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.5 U.K. Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.6 Italy Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.7 Russia Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.8 Nordic Countries Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.9 Benelux Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2028
6.6.2 By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2028
6.6.3 China Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.6.4 Japan Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.6.5 South Korea Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.6.6 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.6.7 India Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2028
6.7.2 By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2028
6.7.3 Brazil Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.7.4 Argentina Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2028
6.8.3 Turkey Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.8.4 Israel Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.8.5 Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.8.6 UAE Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Zafgan
7.1.1 Zafgan Corporate Summary
7.1.2 Zafgan Business Overview
7.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.1.5 Zafgan Key News
7.2 Vivus
7.2.1 Vivus Corporate Summary
7.2.2 Vivus Business Overview
7.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.2.5 Vivus Key News
7.3 Shionogi
7.3.1 Shionogi Corporate Summary
7.3.2 Shionogi Business Overview
7.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.3.5 Shionogi Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 Rhythm Pharmaceuticals
7.5.1 Rhythm Pharmaceuticals Corporate Summary
7.5.2 Rhythm Pharmaceuticals Business Overview
7.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.5.5 Rhythm Pharmaceuticals Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 Orexigen Therapeutics
7.7.1 Orexigen Therapeutics Corporate Summary
7.7.2 Orexigen Therapeutics Business Overview
7.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.7.5 Orexigen Therapeutics Key News
7.8 Novo Nordisk
7.8.1 Novo Nordisk Corporate Summary
7.8.2 Novo Nordisk Business Overview
7.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.8.5 Novo Nordisk Key News
7.9 Norgine
7.9.1 Norgine Corporate Summary
7.9.2 Norgine Business Overview
7.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.9.5 Norgine Key News
7.10 Nalpropion Pharmaceuticals Inc.
7.10.1 Nalpropion Pharmaceuticals Inc. Corporate Summary
7.10.2 Nalpropion Pharmaceuticals Inc. Business Overview
7.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.10.5 Nalpropion Pharmaceuticals Inc. Key News
7.11 Merck
7.11.1 Merck Corporate Summary
7.11.2 Merck Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
7.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.11.4 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.11.5 Merck Key News
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Corporate Summary
7.12.2 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
7.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.12.4 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.12.5 GlaxoSmithKline Key News
7.13 F.Hoffmann-La Roche
7.13.1 F.Hoffmann-La Roche Corporate Summary
7.13.2 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
7.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.13.4 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.13.5 F.Hoffmann-La Roche Key News
7.14 Eisai
7.14.1 Eisai Corporate Summary
7.14.2 Eisai Business Overview
7.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.14.4 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.14.5 Eisai Key News
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Corporate Summary
7.15.2 Boehringer Ingelheim Business Overview
7.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.15.4 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.15.5 Boehringer Ingelheim Key News
7.16 Bayer AG
7.16.1 Bayer AG Corporate Summary
7.16.2 Bayer AG Business Overview
7.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.16.4 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.16.5 Bayer AG Key News
7.17 AstraZeneca
7.17.1 AstraZeneca Corporate Summary
7.17.2 AstraZeneca Business Overview
7.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.17.4 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.17.5 AstraZeneca Key News
7.18 Arena Pharmaceuticals
7.18.1 Arena Pharmaceuticals Corporate Summary
7.18.2 Arena Pharmaceuticals Business Overview
7.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.18.4 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.18.5 Arena Pharmaceuticals Key News
7.19 Amylin
7.19.1 Amylin Corporate Summary
7.19.2 Amylin Business Overview
7.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.19.4 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.19.5 Amylin Key News
7.20 Alizyme
7.20.1 Alizyme Corporate Summary
7.20.2 Alizyme Business Overview
7.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.20.4 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.20.5 Alizyme Key News
8 Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity, Analysis
8.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity, 2017-2028
8.2 Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Obesity Drugs (Anti-obesity Medication) Supply Chain Analysis
10.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Value Chain
10.2 Anti-Obesity Drugs (Anti-obesity Medication) Upstream Market
10.3 Anti-Obesity Drugs (Anti-obesity Medication) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Obesity Drugs (Anti-obesity Medication) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-Obesity Drugs (Anti-obesity Medication) in Global Market
Table 2. Top Anti-Obesity Drugs (Anti-obesity Medication) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Companies, 2017-2022
Table 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Companies, (K Units), 2017-2022
Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
Table 9. List of Global Tier 1 Anti-Obesity Drugs (Anti-obesity Medication) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Obesity Drugs (Anti-obesity Medication) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2017-2022
Table 15. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2023-2028
Table 16. By Application ? Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2017-2022
Table 20. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2023-2028
Table 21. By Region ? Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2017-2022
Table 25. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2023-2028
Table 26. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2017-2022
Table 29. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2023-2028
Table 38. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2017-2022
Table 41. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2023-2028
Table 46. Zafgan Corporate Summary
Table 47. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 48. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Vivus Corporate Summary
Table 50. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 51. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Shionogi Corporate Summary
Table 53. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 54. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 57. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Rhythm Pharmaceuticals Corporate Summary
Table 59. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 60. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 63. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Orexigen Therapeutics Corporate Summary
Table 65. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 66. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Novo Nordisk Corporate Summary
Table 68. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 69. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Norgine Corporate Summary
Table 71. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 72. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Nalpropion Pharmaceuticals Inc. Corporate Summary
Table 74. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 75. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Merck Corporate Summary
Table 77. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 78. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. GlaxoSmithKline Corporate Summary
Table 80. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 81. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. F.Hoffmann-La Roche Corporate Summary
Table 83. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 84. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Eisai Corporate Summary
Table 86. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 87. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Boehringer Ingelheim Corporate Summary
Table 89. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 90. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Bayer AG Corporate Summary
Table 92. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 93. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. AstraZeneca Corporate Summary
Table 95. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 96. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Arena Pharmaceuticals Corporate Summary
Table 98. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 99. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Amylin Corporate Summary
Table 101. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 102. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Alizyme Corporate Summary
Table 104. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 105. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 107. Global Anti-Obesity Drugs (Anti-obesity Medication) Capacity Market Share of Key Manufacturers, 2020-2022
Table 108. Global Anti-Obesity Drugs (Anti-obesity Medication) Production by Region, 2017-2022 (K Units)
Table 109. Global Anti-Obesity Drugs (Anti-obesity Medication) Production by Region, 2023-2028 (K Units)
Table 110. Anti-Obesity Drugs (Anti-obesity Medication) Market Opportunities & Trends in Global Market
Table 111. Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers in Global Market
Table 112. Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints in Global Market
Table 113. Anti-Obesity Drugs (Anti-obesity Medication) Raw Materials
Table 114. Anti-Obesity Drugs (Anti-obesity Medication) Raw Materials Suppliers in Global Market
Table 115. Typical Anti-Obesity Drugs (Anti-obesity Medication) Downstream
Table 116. Anti-Obesity Drugs (Anti-obesity Medication) Downstream Clients in Global Market
Table 117. Anti-Obesity Drugs (Anti-obesity Medication) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Obesity Drugs (Anti-obesity Medication) Segment by Type
Figure 2. Anti-Obesity Drugs (Anti-obesity Medication) Segment by Application
Figure 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2028 (US$, Mn)
Figure 7. Anti-Obesity Drugs (Anti-obesity Medication) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2021
Figure 9. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
Figure 10. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
Figure 13. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
Figure 16. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
Figure 19. US Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
Figure 24. Germany Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 25. France Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
Figure 33. China Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 37. India Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
Figure 40. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
Figure 44. Turkey Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Anti-Obesity Drugs (Anti-obesity Medication) by Region, 2021 VS 2028
Figure 50. Anti-Obesity Drugs (Anti-obesity Medication) Industry Value Chain
Figure 51. Marketing Channels
